Steve Bandak is a physician with a depth of experience in the CNS area. During his career he has had a range of responsibilities, including the design and conduct of clinical studies, building clinical research capabilities and successfully negotiating with regulatory authorities He most recently served as vice president of medical and regulatory affairs with Novavax, Inc. in Rockville, MD., but the majority of his career was with pharmaceutical giant Eli Lilly where he rose to the position of Medical Director. At Lilly, Steve was involved in the development of Prozac®; Zyprexa®, Cymbalta® and Strattera® as well as building clinical research capabilities and successfully negotiating with regulatory authorities. Steve was educated and trained in Guy's Hospital Medical School, University of London and did his internship and internal medicine residency at Guy's Group Hospitals in London and neurology residency at the Royal Free Hospital in London.